Qube Research & Technologies (QRT)
CYCN icon

Qube Research & Technologies (QRT)’s Cyclerion Therapeutics CYCN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-590
Closed -$72K – 1876
2020
Q3 		$72K Buy
+590
New +$67.5K ﹤0.01% 1520

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CYCN Position: Q4 2020 in Review

Qube Research & Technologies (QRT) sold out of Cyclerion Therapeutics (CYCN) in Q4 2020, closing a stake of 590 shares — an estimated $72K sold.

Qube Research & Technologies (QRT) first reported a position in CYCN in Q3 2020 and held it in 1 quarter. The position peaked at $72K in Q3 2020. 73 funds tracked by Wall St. Rank hold CYCN as of Q4 2020.

  • Qube Research & Technologies (QRT) reported no remaining Cyclerion Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 590 Cyclerion Therapeutics shares in Q4 2020, an estimated $72K.
  • Qube Research & Technologies (QRT) first reported a position in Cyclerion Therapeutics in Q3 2020 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Cyclerion Therapeutics position peaked at $72K in Q3 2020.
  • 73 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q4 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2020, filed 16 Feb 2021.